We have excellent results in the preliminary testing of RightOn Cancer Sequencing Kits, conducted in collaboration with the Pathology Department of Massachusetts General Hospital (MGH). If you are interested in validating the MGH results, or using RightOn Cancer Sequencing Kits to advance your cancer research, we would like to hear from you.

For research collaborators, we offer special pricing on RightOn Cancer Sequencing Kits as well as research co-authoring publication opportunities. Please contact Elim BioPharm for more details.